Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole versus risperidone in children and adolescents with tic disorders
IRCT201301053930N17Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aripiprazole and risperidone in tic disorder (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in tic severity. Started Aug 2012; status: completed.
02
Drugs
aripiprazolerisperidone
03
Conditions
tic disorder
Beyond the preview
Go deeper on IRCT201301053930N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201301053930N17.